Despite critical roles of IL-35 in suppressing inflammatory diseases 18-20 and promoting tumor metastasis by suppressing cytotoxic CD8+ anti-tumor T cells, gaps in mechanistic understanding of how IL-35 mediates immunosuppression have prevented its therapeutic use in humans. This evidence concerns the gene CD8A and neoplasm.